Berberine Attenuates Myocardial Ischemia Reperfusion Injury by Suppressing the Activation of PI3K/AKT Signaling

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2016.3018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Erythropoietin Pretreatment Suppresses Inflammation by Activating the PI3K/Akt Signaling Pathway in Myocardial Ischemia-Reperfusion Injury

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

Clemastine Fumarate Protects Against Myocardial Ischemia Reperfusion Injury by Activating the TLR4/PI3K/Akt Signaling Pathway

Frontiers in Pharmacology
Pharmacology
2020English

Silencing LncRNA AK139328 Protects Vascular Endothelial Cells From Ischemia-Reperfusion Injury by Increasing PI3K/Akt Signaling

Oncotarget
Oncology
2018English

Inhibition of Autophagy via Activation of PI3K/Akt/mTOR Pathway Contributes to the Protection of Hesperidin Against Myocardial Ischemia/Reperfusion Injury

International Journal of Molecular Medicine
MedicineGenetics
2018English

Neuroprotective Effect of Danhong Injection on Cerebral Ischemia-Reperfusion Injury in Rats by Activation of the PI3K-Akt Pathway

Frontiers in Pharmacology
Pharmacology
2020English

Adenosine A1 Receptor Activation Attenuates Lung Ischemia-Reperfusion Injury

2012English

Calorie Restriction Attenuates Inflammatory Responses to Myocardial Ischemia-Reperfusion Injury

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Hypoxia Inducible Factor-1 Activation by Prolyl 4-Hydroxylase-2 Gene Silencing Attenuates Myocardial Ischemia Reperfusion Injury

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2006English

Seabuckthorn Pulp Oil Protects Against Myocardial Ischemia–Reperfusion Injury in Rats Through Activation of Akt/eNOS

Frontiers in Pharmacology
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy